Two Sigma Securities, LLC Tempest Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.23 - $9.77 $3,217 - $136,692
13,991 Added 65.1%
35,483 $156,000
Q3 2023

Nov 14, 2023
BUY
$0.3 - $1.39 $2,081 - $9,642
6,937 Added 47.66%
21,492 $6,000
Q2 2023

Aug 14, 2023
BUY
$1.12 - $3.76 $16,301 - $54,726
14,555 New
14,555 $18,000

Others Institutions Holding TPST

# of Institutions
34
Shares Held
2.24M
Call Options Held
44.9K
Put Options Held
109K
View Full List

About Tempest Therapeutics, Inc.

TPST Quotes by TradingView
  • Ticker TPST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,418,900
  • Market Cap $9.38M
  • Description
  • Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...
More about TPST
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email